Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. [electronic resource]
Producer: 20090213Description: 216-24 p. digitalISSN:- 1550-6606
- Adenocarcinoma -- enzymology
- Animals
- Antibodies -- blood
- Cancer Vaccines -- administration & dosage
- Carcinoma, Pancreatic Ductal -- enzymology
- Celecoxib
- Cyclooxygenase 2 -- metabolism
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease Progression
- Drug Evaluation, Preclinical
- Drug Therapy, Combination
- Humans
- Indoleamine-Pyrrole 2,3,-Dioxygenase -- antagonists & inhibitors
- Mice
- Mice, Transgenic
- Mucin-1 -- administration & dosage
- Pancreatic Neoplasms -- enzymology
- Pyrazoles -- administration & dosage
- Sulfonamides -- administration & dosage
- Vaccines, Subunit -- administration & dosage
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.